The increasing demand for healthcare and the resulting pressure on available budgets
render priority setting inevitable. If societies aim to improve health and distribute health …

The third section of our Special Task Force report identifies and defines a series of elements
that warrant consideration in value assessments of medical technologies. We aim to …

Objective This systematic review aims to catalogue and describe published applications of
equity-informative cost-effectiveness analysis (CEAs). Methods Following PRISMA …

This articles serves as a guide to using cost-effectiveness analysis (CEA) to address health
equity concerns. We first introduce the" equity impact plane," a tool for considering trade-offs …

Background Advanced therapy medicinal products (ATMPs) are beginning to reach
European markets, and questions are being asked about their value for patients and how …

The concept of a reference case, first proposed by the US Panel on Cost-Effectiveness in
Health and Medicine, has been used to specify the required methodological features of …

A growing number of health care systems internationally use formal economic evaluation
methods to support health care funding decisions. Recently, a range of organizations have …

Abstract Context 'What does 'The Public'think?'is a question often posed by researchers and
policy makers, and public values are regularly invoked to justify policy decisions. Over time …

The oft-applied assumption in the use of Quality Adjusted Life Years (QALYs) in economic
evaluation, that all QALYs are valued equally, has been questioned from the outset. The …

Introduction We estimate societal value of a disease‐modifying Alzheimer's disease (AD)
treatment that reduces progression by 30% in early stages. Methods Using the International …